Physician profile
Steven E Wylie
NPI 1972942688
$5,803.87
in general payments reported to CMS, 2019-2025
11 companies · $264 in 2025
The $264 reported for 2025 was more than what 81% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,795 · 2020: $126 · 2021: $2,510 · 2022: $364 · 2023: $404 · 2024: $341 · 2025: $264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $991 · Entertainment: $17.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $990.90 |
| Entertainment | $17.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ivoclar Vivadent, INC. | $3,410.83 | 2019-2024 | |
| Patterson Companies, INC. | $827.01 | 2019-2025 | |
| Sirona Dental, INC. | $750.00 | 2019 | |
| Biohorizons Implant Systems INC. | $606.65 | 2021-2025 | Biohorizons, Biohorizons Dental Implants |
| Nobel Biocare USA | $53.70 | 2019 | |
| 3m Company | $49.36 | 2020-2022 | |
| Zimmer Biomet Holdings, INC. | $30.21 | 2020 | |
| Orapharma, A Division of Bausch Health US, LLC | $25.53 | 2019-2021 | |
| Align Technology, INC. | $19.00 | 2019 | |
| Coltene Whaledent INC. | $17.80 | 2024 | |
| Dentsply Sirona INC | $13.78 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Wylie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.